当前位置:首页 - 行情中心 - 佛慈制药(002644) - 财务分析 - 现金流量表

佛慈制药

(002644)

  

流通市值:43.41亿  总市值:43.41亿
流通股本:5.11亿   总股本:5.11亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金505,443,465.26214,169,482.28887,026,778.36583,947,456.1
  收到的税费返还5,048,823.821,721,960.896,246,198.364,089,988.31
  收到其他与经营活动有关的现金28,337,558.8717,602,684.9350,125,956.5527,314,580.23
  经营活动现金流入小计538,829,847.95233,494,128.1943,398,933.27615,352,024.64
  购买商品、接受劳务支付的现金193,997,416.5886,635,597.02352,926,756.11269,432,053.2
  支付给职工以及为职工支付的现金79,352,218.5140,327,442.77151,360,204.29103,881,068.07
  支付的各项税费55,961,874.9827,216,883.11106,821,009.4881,345,953.39
  支付其他与经营活动有关的现金49,158,969.1223,326,634.33148,341,615.9267,187,728.09
  经营活动现金流出小计378,470,479.19177,506,557.23759,449,585.8521,846,802.75
  经营活动产生的现金流量净额160,359,368.7655,987,570.87183,949,347.4793,505,221.89
二、投资活动产生的现金流量:
  取得投资收益收到的现金392,671.23---
  处置固定资产、无形资产和其他长期资产收回的现金净额--270,312.73-
  投资活动现金流入的平衡项目0-0-
  投资活动现金流入小计392,671.23-270,312.73-
  购建固定资产、无形资产和其他长期资产支付的现金25,677,935.831,798,162.1918,548,451.0611,798,690.52
  投资支付的现金--20,000,000-
  支付其他与投资活动有关的现金--18,867.926,000,000
  投资活动现金流出小计25,677,935.831,798,162.1938,567,318.9817,798,690.52
  投资活动产生的现金流量净额-25,285,264.6-1,798,162.19-38,297,006.25-17,798,690.52
三、筹资活动产生的现金流量:
  取得借款收到的现金2,000,000016,000,00014,000,000
  收到其他与筹资活动有关的现金---0
  筹资活动现金流入小计2,000,000016,000,00014,000,000
  偿还债务支付的现金16,436,80013,200,00023,900,00030,124,520
  分配股利、利润或偿付利息支付的现金10,515,461.34239,233.337,024,032.67,809,468.62
  支付其他与筹资活动有关的现金--928,892.78-
  筹资活动现金流出小计26,952,261.3413,439,233.3331,852,925.3837,933,988.62
  筹资活动产生的现金流量净额-24,952,261.34-13,439,233.33-15,852,925.38-23,933,988.62
四、汇率变动对现金及现金等价物的影响---188,980.2-
五、现金及现金等价物净增加额110,121,842.8240,750,175.35129,610,435.6451,772,542.75
  加:期初现金及现金等价物余额524,492,565.97524,492,565.97394,882,120.33396,897,007.66
  期末现金及现金等价物余额634,614,408.79565,242,741.32524,492,555.97448,669,550.41
补充资料:
  净利润37,955,735.58-46,955,016.44-
  资产减值准备7,457,061.83-58,440,046.99-
  固定资产和投资性房地产折旧29,625,854.3-50,658,704.67-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧29,625,854.3-50,658,704.67-
  无形资产摊销1,646,798.46-3,433,417.49-
  长期待摊费用摊销755,402.29-3,608,545.08-
  处置固定资产、无形资产和其他长期资产的损失---7,131,603.77-
  固定资产报废损失---270,312.73-
  财务费用548,392.88-944,455.11-
  投资损失2,771,744.55-13,537,423.9-
  递延所得税1,931,219.77--4,614,497.68-
  其中:递延所得税资产减少1,347,112.84--3,982,866.39-
    递延所得税负债增加584,106.93--631,631.29-
  存货的减少-18,582,162.57-48,357,921.3-
  经营性应收项目的减少-63,409,437.28--86,743,167.15-
  经营性应付项目的增加158,801,725.28-55,562,229.23-
  现金的期末余额634,614,408.79-524,492,555.97-
  减:现金的期初余额524,492,565.97-394,882,120.33-
  现金及现金等价物的净增加额110,121,842.82-129,610,435.64-
公告日期2026-08-202026-04-302026-04-092025-10-29
审计意见(境内)标准无保留意见
TOP↑